Labshake search
Citations for Tocris :
151 - 200 of 889 citations for Natural Cytotoxicity Triggering Receptor 1 NCR1 Antibody since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... 0.3 or 1 mg/kg of the mGlu2/3 receptor agonist LY379268 (Cat No.: 2453, Batch No.: 9B/232416, CAS No.: 191471-52-0, Tocris Bioscience ...
-
bioRxiv - Neuroscience 2023Quote: ... were dissolved in HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190, 40 µM; Nimodipine, Tocris, 0600 ...
-
bioRxiv - Neuroscience 2023Quote: ... sIPSC recordings were performed in voltage clamp mode in the presence of 20 μM AMPA/Kainate receptor antagonist CNQX (Tocris) and 50 μM NMDA receptor antagonist AP5 (Tocris) ...
-
bioRxiv - Developmental Biology 2023Quote: ... The average baseline EPSP was established with a minimum of 20 sweeps before adding glutamate receptor antagonists (10 μM NBQX (Tocris) and 10 μM CPP (Tocris) ...
-
bioRxiv - Neuroscience 2024Quote: ... another group of animals received an ip injection of WIN55,212-2 (0.5 mg/kg) along with CB1 receptor antagonist SR141716A (0.5 mg/kg, ip) (Tocris Bioscience, Bristol, UK). Rats were randomly selected for each group ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... were recorded at −70 mV and isolated by using the GABAA receptor blocker gabazine 10 mM (SR 95531 hydrobromide; Tocris).
-
bioRxiv - Neuroscience 2023Quote: ... we recorded at −70mV for 48s and for 24s in the presence of the AMPA-receptor antagonist NBQX (3μM) (Tocris Bioscience) diluted in extracellular solution ...
-
bioRxiv - Neuroscience 2021Quote: ... DIV12-13 neurons were pre-treated for 20 minutes with 40 ng/ml of the CXCR2 (CXCL1 receptor in neurons) antagonist SB225002 (Tocris Bioscience), prior to the addition of 40 nM recombinant mouse CXCL1 (R&D Systems ...
-
bioRxiv - Neuroscience 2021Quote: The contribution of activity-dependent incorporation of GluA1 subunit containing AMPA receptors to expression of low repeat t-LTP was verified by postsynaptic application of Pep1-TGL (100 µM, Tocris, Germany) via the patch pipette solution ...
-
bioRxiv - Physiology 2021Quote: ... Picrotoxin (100 µM) was used to block GABAA-receptor-mediated currents and D-2-amino-5-phosphonovalerate (APV; 20 µMm, Tocris Bioscience), and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX ...
-
bioRxiv - Cell Biology 2021Quote: ... AMPAR- and NMDAR-EPSC postsynaptic currents were pharmacologically isolated by adding the GABAA receptor blocker picrotoxin (50 μM) (Tocris Cat#1128) to the extracellular bath solution ...
-
bioRxiv - Neuroscience 2023Quote: ... Experiments were performed at room temperature in oxygenated ACSF containing 50 μM of the GABAA receptor antagonist picrotoxin (Tocris, Ellisville, MO). Recordings from synapses that were silent (failure of transmission at -70 mV ...
-
bioRxiv - Neuroscience 2021Quote: ... The bath solution usually contained 6,7-dinitroquinoxaline-2,3-dione (DNQX, 10 µM) and D- aminophosphonovaleric acid (D-APV, 50 µM) to block ionotropic glutamate receptors (Tocris, Abingdon, United Kingdom). Patch electrodes had resistances of 4-6 MΩ when filled with KMeSO4- or CMeSO4-based internal solution (same as used in vivo) ...
-
bioRxiv - Neuroscience 2020Quote: ... co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris; 20 μM) (n=13) ...
-
bioRxiv - Physiology 2020Quote: ... The MOR antagonist CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2, lidocaine, the Ampakine CX614, and the 5-HT4A receptor agonist BIMU8 were obtained from Tocris (ON, Canada).
-
bioRxiv - Neuroscience 2022Quote: ... these experiments were performed in the presence of AMPA and NMDA receptor blockade (10 µM NBQX and 50 µM D-AP5 respectively; Tocris, Bristol, UK). To isolate excitatory currents ...
-
bioRxiv - Neuroscience 2023Quote: ... [Cl-]i measurements were performed by activating either GABAA or glycine receptors by delivering short ‘puffs’ of GABA (Tocris Bioscience, 100 μM) via a patch pipette placed in the vicinity of the cell soma and connected to a picospritzer (5–10 psi for 20– 40 ms ...
-
bioRxiv - Neuroscience 2021Quote: ... [Cl-]i measurements were performed by activating either GABAA or glycine receptors by delivering short ‘puffs’ of either GABA (Tocris Bioscience, 100 μM) or glycine (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2019Quote: ... surgeries a single dose (0,6 mg/kg dissolved in phosphate buffer or saline) of P2Y12 receptor (P2Y12R) antagonist (PSB0739 Tocris, R&D Systems, Minneapolis, USA) was administered to the cisterna magna in 5 µl final volume using a glass capillary ...
-
bioRxiv - Neuroscience 2023Quote: ... WT mice were infected with 105 pfu of MA-10 SARS-CoV-2 in the presence of placebo or CGRP-receptor antagonist olcegepant slow-release pellets (olcegepant, BIBN4096, Tocris; 2 mg/kg/day/SQ) or mice lacking CGRP were infected with the same virus ...
-
bioRxiv - Neuroscience 2023Quote: ... WT mice were infected with 105 pfu of MA-10 SARS-CoV-2 in the presence of placebo or CGRP-receptor antagonist olcegepant slow-release pellets (olcegepant, BIBN4096, Tocris; 2 mg/kg/day/SQ) or mice lacking CGRP were infected with the same virus ...
-
bioRxiv - Immunology 2020Quote: ... Sigma Aldrich] 30 min prior to activation followed by treatment with 5μg/mL anti-IgM and 1,25μg/mL CpG or were first activated with anti-IgM/CpG for 4h followed by incubation with indicated concentrations of α- or ß-adrenergic receptor (ADR) agonists (ADRA1: (R)-(-)-Phenylephrine hydrochloride (Tocris, Bristol, UK, catalogue number: 2838), ADRA2 ...
-
bioRxiv - Neuroscience 2021Quote: ... Alexa-fluorophore conjugated secondary antibodies were added in blocking solution for 1 hour at 4°C followed by treatment with Methoxy-X04 (Tocris, 4920) for 15 minutes at room temperature to label amyloid-beta plaques ...
-
bioRxiv - Molecular Biology 2021Quote: ... 1 µM IDE-1 (Tocris), 0.2% (v/v ...
-
bioRxiv - Developmental Biology 2023Quote: ... 1 μM DMH-1 (Tocris) and 3 μM CHIR99021 (Tocris) ...
-
bioRxiv - Developmental Biology 2021Quote: ... and 1 μM IDE-1 and 1 μM XAV939 (both Tocris). 48 hours after the onset of differentiation ...
-
bioRxiv - Developmental Biology 2022Quote: ... 1 μM endo-IWR-1 (Tocris), and 10 μM SB431542 (Stemgent).
-
bioRxiv - Developmental Biology 2023Quote: ... and 1 μM DMH-1 (Tocris) on 6-well ECM collagen-I-coated peptide plates (Corning ...
-
bioRxiv - Developmental Biology 2023Quote: ... and 1 μM DMH-1 (Tocris) and mixed with 90 μl Growth Factor Reduced Matrigel (Corning) ...
-
bioRxiv - Developmental Biology 2021Quote: ... supplemented with 1 μM IDE-1 (Tocris), 0.2% (v/v ...
-
bioRxiv - Developmental Biology 2021Quote: ... supplemented with 1 μM IDE-1 (Tocris), 0.2% (v/v ...
-
bioRxiv - Cancer Biology 2021Quote: ... Torin1 (1 μM, Tocris, 10-1-4247), and AICAR (2 mM ...
-
bioRxiv - Developmental Biology 2022Quote: ... and endothelin 1 (ET-1) from Tocris Bioscience (Bristol ...
-
bioRxiv - Genomics 2021Quote: ... and 1 μM tetrodotoxin (TTX; Tocris #1078/1). KCl (55mM ...
-
bioRxiv - Cell Biology 2022Quote: ... MLSA1 (Tocris, 4746, incubation 1 μM for 1 h). For all experiments in microfluidic chips involving drugs ...
-
bioRxiv - Neuroscience 2020Quote: ... rabbit anti-GLT-1 (Tocris, #2063, dilution 1:2000). Secondary antibodies against mouse ...
-
bioRxiv - Biophysics 2022Quote: ... 50 μL well-1 of 2X neurotensin 1-13 (Tocris) solutions were added to the appropriate well and incubated for an additional 30 min ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 DAMGO (Tocris), 10 Bombesin (Tocris) ...
-
bioRxiv - Cell Biology 2019Quote: ... ITD-1 (Tocris) compound was administrated at 5mM.
-
bioRxiv - Neuroscience 2019Quote: ... and 1% P/S) supplemented with 1 µM purmorphamine (Tocris Bioscience), a SHH agonist ...
-
bioRxiv - Cell Biology 2021Quote: ... and 6-O-[(4,5-Dimethoxy-2-nitrophenyl)methyl]-2,3-O-(1-methylethylidene)-D-myo-Inositol 1,4,5-tris[bis[(1-oxopropoxy)methyl]phosphate] (ci-IP3/PM; 1 μM, Tocris #6210) in imaging buffer with 0.01 % BSA in dark at room temperature ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with FGF-2 (20 ng ml−1), Activin-A (50 ng ml−1), BMP-4 (10 ng ml−1, R&D) and LY294002 (10 mM Tocris). Media was changed again after 42 hours to CDM-BSA supplemented with FGF-2 (8 ng ml−1) ...
-
bioRxiv - Immunology 2019Quote: ... 1 uM capsaicin (Tocris) and 40 mM KCl (Sigma ...
-
bioRxiv - Neuroscience 2020Quote: ... dAP5 (1 mM, Tocris) was topically applied to the dura mater ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 μM dexamethasone (Tocris) and 10 nM LONG R3 IGF-1 (IGF ...
-
bioRxiv - Neuroscience 2020Quote: ... MPEP (1 μM, Tocris), NBQX (10 μM ...
-
bioRxiv - Neuroscience 2020Quote: ... 1 μM oxytocin (Tocris) in ACSF was washed on for 10-15 minutes ...
-
bioRxiv - Neuroscience 2020Quote: ... MRS2500 (1 µM, Tocris) was applied by addition to superfused ACSF.
-
bioRxiv - Developmental Biology 2022Quote: ... FIIN-1 (20nM, Tocris), Fgfr2iiib-Fc (1µg/ml ...
-
bioRxiv - Biochemistry 2022Quote: ... SL-0101-1 (Tocris), palbociclib (Sigma) ...